Fibrocor Therapeutics
PrivateLast Round
Strategic
Jan 15, 2020
Total Funding Raised
$2.1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Fibrocor Therapeutics is a biotechnology company that develops first-in-class therapeutics targeting fibrotic diseases, with an initial focus on kidney diseases such as Alport Syndrome and ADPKD.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fibrocor Therapeutics Comparables
Compare Fibrocor Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evotec | 80% | |
| Mirador Therapeutics | 80% | |
| ENYO Pharma | 78% |
Fibrocor Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jan 15, 2020 | ||||
| Seed | Jan 17, 2017 |
Key People
Founding team and executive leadership
Fibrocor Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TIAP | Seed |
| BioGeneration Ventures | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 282% MoM, reaching 2.5K.
- Jan 15, 2020
Raised capital from BioGeneration Ventures and Lakefront Biotherapeutics NV.
Fibrocor Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Fibrocor Therapeutics's valuation, stock price, and market status.
Is Fibrocor Therapeutics a public or private company?
Fibrocor Therapeutics is a private company.
What is the current stock price of Fibrocor Therapeutics?
Fibrocor Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Fibrocor Therapeutics worth (valuation)?
Valuation information for Fibrocor Therapeutics is not publicly available.
Can I buy Fibrocor Therapeutics stock?
Fibrocor Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Fibrocor Therapeutics's last funding round?
Fibrocor Therapeutics's most recent funding round was Strategic on January 15, 2020.
Who are the main investors in Fibrocor Therapeutics?
Key investors in Fibrocor Therapeutics include TIAP, BioGeneration Ventures.
Will Fibrocor Therapeutics IPO soon?
No public IPO plans have been announced for Fibrocor Therapeutics.
How can I track Fibrocor Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Fibrocor Therapeutics's secondary market activity and sign up for updates.